NCT03150420 — Calciphylaxis trial site landscape

Public-registry site landscape for NCT03150420, a Calciphylaxis study sponsored by Hope Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03150420 (registry record)
Sponsor	Hope Pharmaceuticals
Condition(s)	Calciphylaxis
Phase	PHASE3
Listed sites	21
Site countries	United States, Canada, United Kingdom

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03150420 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.